NCT02208505View on ClinicalTrials.gov

Antitussive Effect of Single-dose Dexmedetomidine With Low-dose Remifentanil Infusion

PHASE4CompletedINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

December 31, 2015

Conditions
Thyroidectomy
Interventions
DRUG

Dexmedetomidine + Remifentanil-low dose

single dose administration (0.5mcg/kg) 10 min before end of the surgery with maintain the infusion of remifentanil (TCI 1 ng/ml) until end of surgery

DRUG

Remifentanil-high dose

maintain the infusion of remifentanil until end of the surgery (TCI 2 ng/ml)

Trial Locations (1)

135-720

Gangnam severance hospital, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT02208505 - Antitussive Effect of Single-dose Dexmedetomidine With Low-dose Remifentanil Infusion | Biotech Hunter | Biotech Hunter